Phase 2 Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older
- Your cancer must be a solid tumor that has spread to other parts of the body, confirmed by a tissue or cell sample test
- You must be fairly active and able to care for yourself, with only minor limitations on physical activity (confirm with trial site regarding exact fitness level required)
- You must have at least one area of cancer that can be measured on a scan
- You must be willing to use an approved form of contraception during the study, in line with local guidelines
- Your blood counts, liver, and kidney must be working well enough to meet the study's requirements
- You must be able to understand and sign a consent form agreeing to participate
Who may not be able to join:
- People with significant heart problems or heart disease
- People who still have unresolved side effects from previous cancer treatments
- People who have had an organ transplant or bone marrow/blood cell transplant in the past
- People who have brain metastases (cancer that has spread to the brain) that are untreated or not under control
- People who are HIV positive, or have active hepatitis B or C, or have an ongoing infection that requires IV treatment
- People who have received a live vaccine within 28 days before the planned start of treatment
- People who the study doctor feels are not suitable to participate, for any medical or other reason
- People who are currently taking part in another clinical trial during the treatment period
- People with a known allergy to the study drug MDX2001 or any of its components
- People who need supplemental oxygen for everyday activities
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (857) 233-9936
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
All Phases: Adverse events (AEs); Phase 1b and Phase 2a: Objective response rate of MDX2001; Phase 1: Recommended Phase 2 dose (RP2D)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.